ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08612
-0,06%
Bitcoin
65.707,96
0,72%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Foamix Pharmaceuticals Ltd (FOMX)

  7. Foamix Pharmaceuticals Ltd (FOMX) News

FOMX

Foamix Pharmaceuticals (FOMX)

Foamix Pharmaceuticals Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FOMX
DatumZeitQuelleÜberschriftSymbolFirma
23/03/202011h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/03/202020h10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202014h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/202022h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
10/03/202011h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/202014h27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202023h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202022h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:FOMX

Kürzlich von Ihnen besucht

TSXV
AXM
AXMIN
BIT
UC6127
Unicredit Bank
LSE
VOF
Vinacapital Vietnam Oppo...
ASX
JKANA
USOTC
SRMX
Saddle Ranch Media (PK)
LSE
US10
Amundi Ust Lgd
BIT
UB5774
Unicredit Bank
ASX
MNDKOP
HUOB
AUDIOUSDT
Audius
LSE
TRCS
Tracsis
LSE
SM29
Citi Fun 25
BIT
UB8PCS
Unicredit Bank
NYSE
FATH.WS
Fathom Digital Manufactu...
USOTC
WDTK
WedoTalk (CE)
BIT
UB82DS
Unicredit Bank
BIT
F13992
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten